• Aim to support treatment by healthcare providers and caregivers for patients
• Completely private tool for medical care in consideration with patients’ privacy

TOKYO, Sep 30, 2019 -- Chugai Pharmaceutical Co., Ltd. (TOKYO) and Embrace Co., Ltd. (TOKYO) announced today that the both company developed and started to provide a treatment support tool for patients with rheumatoid arthritis, lupus nephritis, and chronic kidney disease.

This web tool provides treatment support according to the characteristics of the three diseases using a completely private medical care SNS MedicalCareStation (MCS) developed by Embrace. Some patients receive regular visits from several healthcare providers and caregivers, however, they do not always share information with each other. In addition, patients who live far away from their hospital may visit their healthcare providers less frequently, and do not receive enough follow-up for a long time until the next visit. By sharing and reviewing changes in symptoms and physical conditions among patients, healthcare providers and caregivers, better therapeutic practice is expected. Since the information on the tool is completely private for non-specified users, patients can safely communicate with healthcare providers and caregivers. The app offers the following features;

• Enable easy entry of physical conditions and symptoms of concern by patients/their families, healthcare providers and caregivers
• Send notifications on a regular basis to prevent data entry omission
• Share physical condition and symptoms of concern amongpatients, healthcare providers and caregivers
• Display alert messages for patients/their families, healthcare providers and caregivers, depending on the severity of symptoms of concern
• Support Communication among patients/their families, healthcare providers and caregivers

This tool is using MCS, a medical SNS used widely in Japan as a platform and is planned to expand into the osteoporosis area in the future. MCS has been formally adopted by over 200 medical associations and registered by about 90,000 healthcare providers and caregivers in Japan.

Chugai and Embrace aim to contribute to healthcare by promoting treatment support through the development of patient-centered multidisciplinary communication.

Details of the apps for three disease areas
[Physical condition check tool for patients with rheumatoid arthritis (RA)]
Clinical symptoms often seen in RA can be easily shared between patients, healthcare providers and caregivers. This tool can be used for health management of elderly patients living alone, as well as for follow-up of patients living far away from their hospital.

About Chugai
Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription pharmaceuticals and is listed on the 1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs, mainly focusing on the oncology area.
Additional information is available on the internet at https://www.chugai-pharm.co.jp/english/.

About Embrace
Embrace’s vision is to visualize issues on medical care in the world and to solve them through communication. Embrace provides MedicalCareStation (MCS), a completely private SNS for medical care, which has been formally adopted by over 200 medical associations. We focus on solving issues that has been and will be caused by the ‘Aging Society’ and we try to realize the multidisciplinary collaboration in community-based integrated care systems to meet the needs in medical care.